Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +36.36%
#2 Versatize Coin Versatize Coin +32.50%
#3 Purr Purr +30.40%
#4 Siren Siren +30.34%
#5 ApeX ApeX +15.66%
#6 OriginTrail OriginTrail +15.24%
#7 Pendle Pendle +14.37%
#8 UnifAI Network UnifAI Network +13.81%
#9 龙虾 (Lobster) 龙虾 (Lobster) +13.15%
#10 Morpho Morpho +13.10%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
설정
언어
한국어
통화
USD
테마
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
주식 순위 #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
주가
$3.01
마지막 동기화: 2024-04-12
시가총액
$104.64M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Cyteir Therapeutics, Inc. (CYT)

카테고리

Healthcare
Cyteir Therapeutics, Inc. (CYT)의 주가 이력
최고 종가: $3.01 (2024-04-01 기준)

최저 종가: $18.73 (2021-06-01 기준)
Cyteir Therapeutics, Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2024 -2.00%
2023 125.69%
2022 -88.47%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH